to clarify the mechanisms of anti-tumor activity of human recombinant tumor necrosis factor alpha ( rtnf alpha ) , an established cell line ku-2 , derived from a patient with human renal cell carcinoma ( rcc ) , was treated with rtnf alpha alone or in combination with anti-cancer agents : actinomycin-d ( acd ) , vinblastine sulfate ( vlb ) , nimustine hydrochloride ( acnu ) , and methotrexate ( mtx ) .
C0042671
vinblastine sulfate
C0042670
vlb